Compare PVLA & WB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PVLA | WB |
|---|---|---|
| Founded | 2015 | 2009 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.7B |
| IPO Year | 2013 | 2014 |
| Metric | PVLA | WB |
|---|---|---|
| Price | $130.71 | $6.58 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 17 |
| Target Price | ★ $228.93 | $8.24 |
| AVG Volume (30 Days) | 191.6K | ★ 874.6K |
| Earning Date | 11-10-2026 | 11-17-2026 |
| Dividend Yield | N/A | ★ 9.32% |
| EPS Growth | ★ 52.62 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $42,810,000.00 | N/A |
| Revenue This Year | N/A | $0.11 |
| Revenue Next Year | N/A | $0.78 |
| P/E Ratio | ★ N/A | $5.66 |
| Revenue Growth | ★ 65.28 | N/A |
| 52 Week Low | $68.96 | $6.27 |
| 52 Week High | $161.38 | $11.72 |
| Indicator | PVLA | WB |
|---|---|---|
| Relative Strength Index (RSI) | 37.87 | 46.92 |
| Support Level | $109.68 | $6.47 |
| Resistance Level | $135.23 | $6.79 |
| Average True Range (ATR) | 7.07 | 0.10 |
| MACD | -0.56 | 0.04 |
| Stochastic Oscillator | 21.32 | 84.93 |
Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies. Its product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations and cutaneous venous malformations. It operates in single segment.
Weibo Corp is a China-based company that operates a social media platform for people to create, discover and distribute content. The company currently operates and manages its business in two principal business lines globally - advertising and marketing services and value-added services. The Value-added Services mainly provide services such as membership services on social platforms, online games, live broadcasts, social e-commerce, and others. The company's main product is the social platform Weibo. It generates a substantial majority of its revenues from online advertising and marketing services.